These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3765712)

  • 1. The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.
    Khomenko AG; Insanov AB
    Z Erkr Atmungsorgane; 1986; 167(1-2):163-7. PubMed ID: 3765712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levamisole and diucifon immunochemotherapy of chronic destructive pulmonary tuberculosis].
    Khomenko AG; Insanov AB
    Probl Tuberk; 1984 Sep; (9):23-7. PubMed ID: 6504881
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of the treatment of experimental destructive pulmonary tuberculosis with antibacterial drugs combined with levamisole and diucifon].
    Khomenko AG; Erokhin VV; Insanov AB; El'shanskaia MP; Golyshevskaia VI
    Probl Tuberk; 1984 Apr; (4):55-9. PubMed ID: 6739463
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
    Ivanova LA
    Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of resistant pulmonary tuberculosis using chemotherapy and immunomodulators].
    Olmedo Zenteno C; López Aja J; Rojas García O; Salazar Riverol H; Yarce Palacios E
    Salud Publica Mex; 1983; 25(2):151-9. PubMed ID: 6879325
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems of epidemiology, diagnosis and treatment of caseous pneumonia].
    Kibrik BS; Chelnokova GA
    Probl Tuberk; 2002; (9):18-22. PubMed ID: 12524982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI; Pisarevskaia LI; Nikishina EV
    Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-immunologic aspects of patients with chronic obstructive bronchitis. Immunomodulating therapy].
    Martsinovskiĭ VIu; Sil'vestrov VP; Karaulov AV
    Ter Arkh; 1983; 55(12):61-4. PubMed ID: 6607547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative characteristics of immunomodulators in the combined treatment of patients with mandibular fractures].
    Zuev VP; Evglevskaia IuP; Tikhonova GB
    Stomatologiia (Mosk); 1985; 64(2):34-6. PubMed ID: 3873727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of decaris in the complex treatment of destructive pulmonary tuberculosis].
    German AK; Logiĭko VL
    Vrach Delo; 1981 Aug; (8):81-3. PubMed ID: 7269517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effectiveness of diucifon in acute pneumonia based on clinico-immunological and bronchoscopic study data].
    Ermakov EV; Kolomoets NM; Novozhenov VT; Gorlina NK; Leskov VP
    Ter Arkh; 1983; 55(3):41-7. PubMed ID: 6344302
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation of the cyclic nucleotide and calcitonin levels and the cellular immunity indices in true eczema patients].
    Kubanova AA; Vasil'eva LL; Zolotukhin SV; Suchkova ShN
    Vestn Dermatol Venerol; 1984 Jul; (7):16-20. PubMed ID: 6089468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis].
    Naubet'iarova AN; Syzdykova NS; Alenova AKh
    Probl Tuberk; 1987; (4):34-6. PubMed ID: 3110764
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI; Gergert VIa; Khomenko IS
    Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic pathomorphosis. Effect of immunostimulator levamisole on the morphology of specific inflammation under experimental conditions].
    Kireeva SG; Selitskaia RP
    Arkh Patol; 1982; 44(11):38-43. PubMed ID: 7159236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of patients with destructive pulmonary tuberculosis with indomethacin and tuberculostatic preparations].
    Litvin LM; Novosad MK
    Vrach Delo; 1990 May; (5):76-8. PubMed ID: 2396403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems of the epidemiology, diagnosis, and treatment of caseous pneumonia].
    Kibrik BS; Chelnokova OG
    Probl Tuberk Bolezn Legk; 2004; (12):25-9. PubMed ID: 15719662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.